BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

V.I. Technologies Incorporated

V.I. Technologies is a leading developer of a broadportfolio of blood products and systems which use its proprietary pathogen

inactivation technologies. The Company's technologies are intended to address the risks of viral, bacterial and other pathogen contamination in blood products, including plasma, plasma derivatives, red blood cells and platelets. Viral inactivation processes have the potential to eliminate viruses that are enveloped by lipid membranes such as

hepatitis B virus ("HBV"), hepatitis C virus ("HCV") and HIV, the virus that

causes AIDS, and non-enveloped viruses such as hepatitis A virus ("HAV") and

parvovirus and other known and unknown pathogens.


Contact Details:
134 Coolidge Avenue
Watertown
MA
02472
United States of America
Tel:(617) 926-1551
Fax:
Email:info@vitechnologies.com

Loading...

Recent Publications by V.I. Technologies Incorporated:

Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents.
BACKGROUND: Cytomegalovirus (CMV) is transmitted by transfusion of...
18th October, 2006
V.I. Technologies, Inc., Watertown, Massachusetts, USA. Transfusion. 2006 Sep;46(9):1580-8.
DOI Direct Link
Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry.
BACKGROUND AND OBJECTIVES: The risk of transfusion-transmitted bacterial...
30th March, 2005
V. I. Technologies, Inc., Watertown, MA 02472, USA. Vox Sang. 2004 Oct;87(3):143-9.
DOI Direct Link
Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110.
BACKGROUND AND OBJECTIVES: Two different leucocyte-inactivation...
14th October, 2004
V. I. Technologies, Inc., Watertown, MA 02465, USA. Vox Sang. 2004 Jul;87(1):1-9.
DOI Direct Link
Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry.
BACKGROUND: The transmission of parasites, including Babesia, plasmodia,...
3rd June, 2004
V.I. Technologies, Inc., Watertown, Massachusetts 02472, USA. Transfusion. 2004 May;44(5):731-8.
DOI Direct Link
Inactivation of mycoplasma species in blood by INACTINE PEN110 process.
BACKGROUND: Mycoplasmas have been associated with multiple acute and...
24th March, 2004
V. I. Technologies, Inc., Watertown, Massachusetts 02472, USA. Transfusion. 2004 Feb;44(2):286-93.

View more V.I. Technologies Incorporated research publications.

BioNews Results for V.I. Technologies Incorporated:

Learn about the World Molecular Diagnostics Market
Prudent Press Agency:  Jun 25 2008 9:32AM Matching: v technologies
Emisphere Announces License Agreement With Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonists
SmartBrief:  Jun 26 2008 12:59PM Matching: v technologies
Emisphere, Nordisk pact to develop oral formulation of GLP-1 receptor agonists for diabetes
PharmaBiz:  Jun 25 2008 8:37AM Matching: v technologies
Learn about the World Molecular Diagnostics Market
Market Wire:  Jun 24 2008 4:07PM Matching: v technologies
Learn about the World Molecular Diagnostics Market
Canadian Business Magazine:  Jun 24 2008 4:01PM Matching: v technologies
Promote your company here: BioNewsCast - Press Release Distribution

View more V.I. Technologies Incorporated news.

V.I. Technologies Incorporated Patents:

US Patent No.Title
6774123 Methods and compositions for inactivating viruses
6093564 Methods and compositions for the selective modification of nucleic acids
6114108 Methods and compositions for the selective modification of viral nucleic acids
6215003 Synthesis of ethyleneimine dimer
6352695 Methods and compositions for the selective modification of nucleic acids

View more V.I. Technologies Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 359 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: V.I. Technologies | V I Technologies Inc. | the winding road from ideas to income nature | t | vi tecnologies watertown ma | V.I. Technologies | vi technologies | V.I. Technologies | Vi Technologies | VI Technology blood products | .

Search for more companies in Watertown

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for V.I. Technologies Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.